USFDA issues 6 observations to Glenmark Baddi Facility

The company said that it is committed to undertake all necessary steps required to address their observations at the earliest.

573
USFDA
Picture: Pixabay

Last Updated on June 25, 2022 by The Health Master

The drug maker Glenmark Pharmaceuticals announced that the US drug regulator has issued Form 483 with six observations to the company’s formulation manufacturing facility in Baddi, Himachal Pradesh (India).

The U.S. Food and Drug Administration (USFDA) has issued Form 483 with six observations after an inspection at Glenmark Pharmaceuticals’ formulation manufacturing facility based out of Baddi in Himachal Pradesh (India) between 13 June 2022 and 22 June 2022.

The facility caters to the production of oral solids and liquid orals, external preparations like lotions, creams and respiratory segment products.

The company said that it is committed to undertake all necessary steps required to address their observations at the earliest.

“The company is committed to maintaining the highest quality and compliant manufacturing standards at all of its facilities across the globe,” it added.

Glenmark Pharmaceuticals is a global pharmaceutical company with a presence across specialty, generics, and OTC businesses.

USFDA issues 8 Observations to Panacea Biotec for Baddi Facility

USFDA gives 5 observations to Glenmark Pharma for Goa facility

USFDA gives 10 observations to Sun Pharm

USFDA gives Zero Observations to SMS Lifesciences

USFDA issues 4 Observations to Lupin for Tarapur Facility

USFDA gives 13 observations to Lupin

Haryana became the first state in the country to issue Drug Manufacturing Licenses online: HM

Govt notifies Surrogacy (Regulation) Rules for Surrogacy Clinics

UAFDA approves first Alopecia Drug that restores Hair Growth

Govt told to decide affordable price of Cancer Drug

Govt told to decide affordable price of Cancer Drug

Now TDS On Free Physician Samples

High Court to PCI: Open its portal for Pharmacy Colleges to submit application

Blood Bank / Centre: Difference Between SDP and RDP

Govt relaxes dossier filing norm for Medical Devices

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner